4/A
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001578563-20-000018
Chief Financial Officer acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Miller Joseph M · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-07-12 | Grant or award : show line 1 in the form | +45,000 | 45,000 | D |
Loading xslF345X03/primary_doc.xml…